These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 20723329)

  • 1. [Effects of riboflavin combined with photosensitization on reduction of Gram-positive and Gram-negative indicating germs in plasma and P-selectin expression of apheresis platelet concentrates].
    Zhou XY; Xiong W; Kong LK
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):1059-62. PubMed ID: 20723329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional characteristics of apheresis-derived platelets treated with ultraviolet light combined with either amotosalen-HCl (S-59) or riboflavin (vitamin B2) for pathogen-reduction.
    Picker SM; Oustianskaia L; Schneider V; Gathof BS
    Vox Sang; 2009 Jul; 97(1):26-33. PubMed ID: 19302416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of bacteria via photosensitization of vitamin K3 by UV-A light.
    Xu F; Vostal JG
    FEMS Microbiol Lett; 2014 Sep; 358(1):98-105. PubMed ID: 25053393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional characteristics and clinical effectiveness of platelet concentrates treated with riboflavin and ultraviolet light in plasma and in platelet additive solution.
    Ignatova AA; Karpova OV; Trakhtman PE; Rumiantsev SA; Panteleev MA
    Vox Sang; 2016 Apr; 110(3):244-52. PubMed ID: 26646605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogen reduction of buffy coat platelet concentrates using riboflavin and light: comparisons with pathogen-reduction technology-treated apheresis platelet products.
    Li J; de Korte D; Woolum MD; Ruane PH; Keil SD; Lockerbie O; McLean R; Goodrich RP
    Vox Sang; 2004 Aug; 87(2):82-90. PubMed ID: 15355498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates.
    Perez-Pujol S; Tonda R; Lozano M; Fuste B; Lopez-Vilchez I; Galan AM; Li J; Goodrich R; Escolar G
    Transfusion; 2005 Jun; 45(6):911-9. PubMed ID: 15934989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic bactericidal effects of pairs of photosensitizer molecules activated by ultraviolet A light against bacteria in plasma.
    Feyissa Q; Xu F; Ibrahim Z; Li Y; Xu KL; Guo Z; Ahmad J; Vostal JG
    Transfusion; 2021 Feb; 61(2):594-602. PubMed ID: 33219568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of platelet concentrates and plasma with riboflavin and UV light: Impact in bacterial reduction.
    Bello-López JM; Delgado-Balbuena L; Rojas-Huidobro D; Rojo-Medina J
    Transfus Clin Biol; 2018 Sep; 25(3):197-203. PubMed ID: 29656962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of use of riboflavin and ultraviolet light for pathogen inactivation on quality of platelet concentrates].
    Stanojković Z; Antić A; Stojanović M
    Vojnosanit Pregl; 2011 Jun; 68(6):489-94. PubMed ID: 21818915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell quality of apheresis-derived platelets treated with riboflavin-ultraviolet light after resuspension in platelet additive solution.
    Picker SM; Tauszig ME; Gathof BS
    Transfusion; 2012 Mar; 52(3):510-6. PubMed ID: 21981030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficiency of riboflavin and ultraviolet light treatment against high levels of biofilm-derived Staphylococcus epidermidis in buffy coat platelet concentrates.
    Taha M; Culibrk B; Kalab M; Schubert P; Yi QL; Goodrich R; Ramirez-Arcos S
    Vox Sang; 2017 Jul; 112(5):408-416. PubMed ID: 28378343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet derived cytokine accumulation in platelet concentrates treated for pathogen reduction.
    Tauszig ME; Picker SM; Gathof BS
    Transfus Apher Sci; 2012 Feb; 46(1):33-7. PubMed ID: 22119364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro study of platelet function confirms the contribution of the ultraviolet B (UVB) radiation in the lesions observed in riboflavin/UVB-treated platelet concentrates.
    Abonnenc M; Sonego G; Crettaz D; Aliotta A; Prudent M; Tissot JD; Lion N
    Transfusion; 2015 Sep; 55(9):2219-30. PubMed ID: 25873361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photochemical inactivation of bacteria and HIV in buffy-coat-derived platelet concentrates under conditions that preserve in vitro platelet function.
    Knutson F; Alfonso R; Dupuis K; Mayaudon V; Lin L; Corash L; Högman CF
    Vox Sang; 2000; 78(4):209-16. PubMed ID: 10895093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Riboflavin and ultraviolet light treatment potentiates vasodilator-stimulated phosphoprotein Ser-239 phosphorylation in platelet concentrates during storage.
    Schubert P; Culibrk B; Coupland D; Scammell K; Gyongyossy-Issa M; Devine DV
    Transfusion; 2012 Feb; 52(2):397-408. PubMed ID: 21827504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of bacterial inactivation in prestorage pooled, leukoreduced, whole blood-derived platelet concentrates suspended in plasma prepared with photochemical treatment.
    Brecher ME; Hay S; Corash L; Hsu J; Lin L
    Transfusion; 2007 Oct; 47(10):1896-901. PubMed ID: 17880617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p38MAPK is involved in apoptosis development in apheresis platelet concentrates after riboflavin and ultraviolet light treatment.
    Chen Z; Schubert P; Culibrk B; Devine DV
    Transfusion; 2015 Apr; 55(4):848-57. PubMed ID: 25385501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell integrity and mitochondrial function after Mirasol-PRT treatment for pathogen reduction of apheresis-derived platelets: Results of a three-arm in vitro study.
    Picker SM; Steisel A; Gathof BS
    Transfus Apher Sci; 2009 Apr; 40(2):79-85. PubMed ID: 19233725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Riboflavin and amotosalen photochemical treatments of platelet concentrates reduce thrombus formation kinetics in vitro.
    Van Aelst B; Feys HB; Devloo R; Vanhoorelbeke K; Vandekerckhove P; Compernolle V
    Vox Sang; 2015 May; 108(4):328-39. PubMed ID: 25557250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes of platelet aggregation function of apheresis collected platelets and soluble P-selectin during storage].
    Xie ZT; Yang LH; Tao ZH; Wang MS; Hong JY; Zhou W; Chen ZQ; Dai MJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1188-91. PubMed ID: 18928625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.